ValGenesis, Inc., a company involved in enterprise validation lifecycle management systems (VLMS), and Brevitas, an independent technology consulting firm, joined forces to introduce the ValGenesis product suite alongside Brevitas’ technical expertise in life sciences across the U.S. and Canada.

ValGenesis’ digital validation platform, which includes its flagship VLMS offering, is designed to help life sciences companies enable stronger compliance, enforce standardization, and further digital transformation across manufacturing operations.

Brevitas will implement and support the ValGenesis product suite, including ValGenesis VLMS, and VLMS Express, a cloud-based validation solution for organizations that need to start small, deploy quickly, and scale. These products enable digitization of the CQV and validation program work Brevitas does for clients. Brevitas will also promote and implement the entire suite of ValGenesis products including iRisk, the vanguard of next-generation risk management platforms; e-Logbook, a fully digital, web-based platform that eliminates the frustrations of paper-based logbooks; and Process Manager, for regulatory compliance and product safety through scientific validation and electronic documentation in the cleaning validation lifecycle.

“We look forward to modernizing life sciences through our strategic partnership with Brevitas. Already onboard with a key win, Brevitas worked to achieve a very successful customer engagement with ValGenesis,” said Bo Olsen, ValGenesis’ senior vice president of Partners. “Leveraging our solutions and combined technical expertise in digital validation, customers will be empowered to navigate complex business challenges to drive meaningful outcomes with confidence.”

“In close collaboration with ValGenesis, Brevitas is dedicated to helping our clients on their digital transformation journey. This partnership empowers our clients to enhance compliance, standardize operations, and foster innovation in manufacturing,” said Anil Peer, principal consultant at Brevitas.